MENU
ABUS
Stock ticker:
PRICE
CHANGE
CAPITALIZATION

Arbutus Biopharma (ABUS) Earnings Date & Reports

Industry: @Biotechnology
A.I. Advisor
published Earnings

ABUS is expected to report earnings to fall 14.55% to -9 cents per share on November 06

Arbutus Biopharma ABUS Stock Earnings Reports
Q3'24
Est.
$-0.09
Q2'24
Missed
by $0.01
Q1'24
Est.
$-0.10
Q4'23
Est.
$-0.12
Q3'23
Missed
by $0.01
The last earnings report on August 01 showed earnings per share of -10 cents, missing the estimate of -10 cents. With 471.18K shares outstanding, the current market capitalization sits at 723.04M.
View a ticker or compare two or three
ABUS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of drugs to improve the treatment of cancer

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
701 Veterans Circle
Phone
+1 267 469-0914
Employees
73
Web
http://www.arbutusbio.com